Mitogenetics Named One of the Top Innovators at the Annual New England Venture Summit in Boston

NEW YORK, NY--(Marketwired - Jan 22, 2015) - Mitogenetics, a South Dakota-based research and development company, has been named one of the Top Innovators at the annual New England Venture Summit. Mitogenetics was named one of 50 Top Innovators from the Technology, Clean tech, and Life Sciences sectors and chosen to present their breakthrough medical technology to an exclusive audience of potential investors.

The Venture Summit is a premier industry event that connects venture capitalists, corporate VCs, angel investors, emerging growth companies, and university researchers with a select group of innovators. For Mitogenetics, it was a key opportunity to generate top-of-mind awareness and visibility among leading industry influencers.

"We are thrilled to have been named one of the top innovators in our field," said Marcia Hendrickson, President and CEO of Mitogenetics. "Our research projects have the chance to lead to major breakthroughs in therapeutic strategies for mitochondrial dysfunction, and I am thrilled we were given the opportunity to present our research to the kind of audience that can help us make a difference."

Mitogenetics, founded in 2010, is focused on the research, development and refinement of biomedical technology, in particular primordial energy control and signaling systems regulating mitochondrial metabolism. The goal is to control mitochondrial energy balance via natural processes and dietary compounds for medicinal remedies.

For more information, visit http://mitogenetics.com/

About Mitogenetics:
Mitogenetics, LLC is a research and development company that is currently focused on the research, development and refinement of biomedical technology, in particular primordial energy control and signaling systems regulating mitochondrial metabolism. Their research projects are leading to major breakthroughs in therapeutic strategies in human diseases disorders that have been functionally linked to cellular mitochondrial dysfunction and pursuing research that will produce commercially viable products for human, plant and animal health. Mitogenetics.com